Distribution of 1298A>C polymorphism of methylenetetrahydrofolate reductase gene in patients with bipolar disorder and schizophrenia

Eur Psychiatry. 2007 Jan;22(1):39-43. doi: 10.1016/j.eurpsy.2006.11.003. Epub 2006 Dec 26.

Abstract

We investigated the genotype frequency of methylenetetrahydrofolate reductase (MTHFR) 1298A>C polymorphism in the group of patients with bipolar disorder type I (BDI) (n=200) and schizophrenia (n=200) and in the control group (n=300). Odds ratio (OR) for patients with BD and schizophrenia in 1298CC homozygous state was 3.768 (95% CI=1.752-8.104); P=0.0003; (P=0.0006 after Bonferroni correction) and 2.694; (95% CI=1.207-6.013); P=0.0123 (P=0.0246 after Bonferroni correction), respectively. The stratification of patients based on gender revealed significant association of 1298CC genotype with female patients only with BDI (OR=7.293; 95% CI=2.017-26.363; P=0.0005). Our results confirm association of BD and schizophrenia with the 1p36.3 MTHFR locus and with the methyl group transfer using folate-dependent one-carbon pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Bipolar Disorder / epidemiology
  • Bipolar Disorder / genetics*
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease / genetics
  • Humans
  • Male
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
  • Middle Aged
  • Odds Ratio
  • Poland / epidemiology
  • Polymorphism, Genetic / genetics
  • Polymorphism, Genetic / physiology*
  • Risk Factors
  • Schizophrenia / epidemiology
  • Schizophrenia / genetics*
  • Sex Factors

Substances

  • Methylenetetrahydrofolate Reductase (NADPH2)